Approval · Notice of Compliance 28456 · 2022
RITALIN: Notice of Compliance 28456
Issued June 23, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28456
- Date
- June 23, 2022
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RITALIN | Not yet assigned | — |
| RITALIN SR | Not yet assigned | — |
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 10 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 20 MG per TAB